Literature DB >> 11841347

Plasminogen activators in vascular remodeling and angiogenesis.

Ye V Parfyonova1, O S Plekhanova, V A Tkachuk.   

Abstract

This review considers cellular and molecular mechanisms of the involvement of plasminogen activators in extracellular proteolysis and cell migration and proliferation. The role of plasminogen activators in vascular remodeling in atherosclerosis, restenosis, and angiogenesis is discussed.

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 11841347     DOI： 10.1023/a:1013964517211

Source DB:  PubMed          Journal:  Biochemistry (Mosc)        ISSN： 0006-2979            Impact factor:   2.487


  13 in total

Review 1.  In stent restenosis: bane of the stent era.

Authors:  A K Mitra; D K Agrawal
Journal:  J Clin Pathol       Date:  2006-03       Impact factor: 3.411

2.  A competitive hexapeptide inhibitor of annexin A2 prevents hypoxia-induced angiogenic events.

Authors:  Mallika Valapala; Sanjay I Thamake; Jamboor K Vishwanatha
Journal:  J Cell Sci       Date:  2011-04-12       Impact factor: 5.285

3.  Adipose-derived mesenchymal stromal cells from aged patients with coronary artery disease keep mesenchymal stromal cell properties but exhibit characteristics of aging and have impaired angiogenic potential.

Authors:  Anastasia Efimenko; Nina Dzhoyashvili; Natalia Kalinina; Tatiana Kochegura; Renat Akchurin; Vsevolod Tkachuk; Yelena Parfyonova
Journal:  Stem Cells Transl Med       Date:  2013-12-18       Impact factor: 6.940

4.  Plasminogen activator inhibitor-1 is a critical downstream target of p53 in the induction of replicative senescence.

Authors:  Roderik M Kortlever; Paul J Higgins; René Bernards
Journal:  Nat Cell Biol       Date:  2006-07-23       Impact factor: 28.824

Review 5.  Pharmacotherapy for end-stage coronary artery disease.

Authors:  Neel R Sodha; Louis M Chu; Munir Boodhwani; Frank W Sellke
Journal:  Expert Opin Pharmacother       Date:  2010-02       Impact factor: 3.889

6.  PEGylated DX-1000: pharmacokinetics and antineoplastic activity of a specific plasmin inhibitor.

Authors:  Laetitia Devy; Shafaat A Rabbani; Mark Stochl; Mary Ruskowski; Ian Mackie; Laurent Naa; Mark Toews; Reinoud van Gool; Jie Chen; Art Ley; Robert C Ladner; Daniel T Dransfield; Paula Henderikx
Journal:  Neoplasia       Date:  2007-11       Impact factor: 5.715

Review 7.  Membrane associated proteases and their inhibitors in tumour angiogenesis.

Authors:  A Noel; C Maillard; N Rocks; M Jost; V Chabottaux; N E Sounni; E Maquoi; D Cataldo; J M Foidart
Journal:  J Clin Pathol       Date:  2004-06       Impact factor: 3.411

Review 8.  Biochemical insights into the role of matrix metalloproteinases in regeneration: challenges and recent developments.

Authors:  I H Bellayr; X Mu; Y Li
Journal:  Future Med Chem       Date:  2009-09       Impact factor: 3.808

9.  Disturbed angiogenic activity of adipose-derived stromal cells obtained from patients with coronary artery disease and diabetes mellitus type 2.

Authors:  Nina A Dzhoyashvili; Anastasia Yu Efimenko; Tatiana N Kochegura; Natalia I Kalinina; Natalia V Koptelova; Olga Yu Sukhareva; Marina V Shestakova; Renat S Akchurin; Vsevolod A Tkachuk; Yelena V Parfyonova
Journal:  J Transl Med       Date:  2014-12-10       Impact factor: 5.531

10.  "Social Life" of Senescent Cells: What Is SASP and Why Study It?

Authors:  A V Borodkina; P I Deryabin; A A Giukova; N N Nikolsky
Journal:  Acta Naturae       Date:  2018 Jan-Mar       Impact factor: 1.845
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.